WebApr 11, 2024 · GSK Financials Summary financials Revenue ( FY, 2024) £34.9B Gross profit ( FY, 2024) £28.4B Net income ( FY, 2024) £5.5B Cash ( FY, 2024) £3.7B EBIT ( FY, 2024) £7.3B Enterprise value $77.6B Competitors and similar companies AstraZeneca Healthcare - Public Eli Lilly Manufacturing & Industrial - Public Johnson & Johnson … WebDec 31, 2024 · GSK Revenue (Annual): 36.31B for Dec. 31, 2024 View 4,000+ Financial Data Types: Add Browse Revenue (Annual) Chart View Full Chart No data available …
GSK delivers FY 2024 reported sales of £34 billion, +1% AER, +3
Web17 hours ago · In that report, analysts expect GSK to post earnings of $0.85 per share. This would mark a year-over-year decline of 22.73%. Meanwhile, the Zacks Consensus Estimate for revenue is... WebGSK CEO Emma Walmsley speaks to CNBC about our full year 2024 results Highlights Downloads FY 2024 results slides (PDF - 801.6KB) 2024 ESG updates at a glance (PDF - 831.9KB) FY 2024 results transcript (PDF - 472.1KB) FY 2024 results infographic (PDF - 90.1KB) FY 2024 US dollar translation (PDF - 355.1KB) fresha sarah galliford calm therapies
GSK plc (GSK) Income Statement - Yahoo Finance
WebFind out how GSK is performing with our latest Annual Report and ESG Performance Report. Annual Report 2024 ESG reports. Web1 day ago · Global key Epoprostenol Sodium Drugs players cover GSK and Teva etc. In terms of revenue, the global two largest companies occupied for a share nearly percent … WebApr 27, 2024 · GSK delivers strong Q1 2024 sales of £9.8 billion, +32% AER, +32% CER; Total EPS 35.9p +67% AER, +66% CER and Adjusted EPS 32.8p +43% AER, +43% … fresha schedule login